The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) |
93.846 |
PAR-25-230 |
| Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) |
93.350 |
RFA-TR-25-002 |
| Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.865, 93.866, 93.867 |
PAR-25-298 |
| Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed) |
93.172, 93.393, 93.394, 93.395, 93.396, 93.399, 93.866 |
RFA-HG-25-007 |
| Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) |
93.233, 93.273, 93.307, 93.361, 93.399, 93.837, 93.838, 93.839, 93.840, 93.853, 93.866 |
PAR-24-330 |
| Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional) |
93.279 |
PAR-25-100 |
| NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 Independent Clinical Trial Not Allowed) |
93.242 |
PAR-24-286 |
| NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed) |
93.121 |
PAR-25-239 |
| Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed) |
93.273, 93.279 |
RFA-DA-26-055 |
| Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed) |
93.273, 93.279 |
RFA-DA-26-056 |
| Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional) |
93.273, 93.307, 93.399 |
PAR-25-299 |
| High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional) |
93.077 |
RFA-OD-25-001 |
| Rehabilitation Research Career Development Programs (K12 Clinical Trial Optional) |
93.865 |
RFA-HD-26-005 |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) |
93.233, 93.837, 93.838, 93.839 |
PAR-25-025 |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-25-026 |
| NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Required) |
93.398 |
PAR-24-319 |
| Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) |
93.866 |
PAR-25-297 |
| Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) |
93.173, 93.242, 93.286, 93.313, 93.399, 93.853, 93.865, 93.867, 93.989 |
PAR-25-242 |
| Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional) |
93.242 |
PAR-25-310 |
| NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) |
93.855 |
PAR-25-251 |
| NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) |
93.213 |
PAR-25-269 |
| Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed) |
93.855 |
PAR-25-300 |
| Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R01 Clinical Trials Required) |
93.279, 93.307, 93.310, 93.313 |
RFA-DA-26-003 |
| Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R34 Clinical Trials Required) |
93.279, 93.310, 93.313 |
RFA-DA-26-004 |
| NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) |
93.213 |
PAR-25-270 |
| NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) |
93.213 |
PAR-25-271 |
| Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) |
93.865 |
PAR-25-266 |
| Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) |
93.865 |
PAR-25-265 |
| Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) |
93.853 |
PAR-25-215 |
| NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed) |
93.398 |
PAR-24-320 |
| Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) |
93.853 |
PAR-25-216 |
| In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed |
93.310 |
RFA-RM-24-012 |
| Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trials Not Allowed) |
93.113, 93.143 |
RFA-ES-25-003 |
| NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Independent Clinical Trial Not Allowed) |
93.398 |
PAR-24-317 |
| NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Clinical Trial Required) |
93.398 |
PAR-24-318 |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.310, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879 |
PAR-25-134 |
| NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) |
93.121 |
PAR-25-188 |
| Artificial Intelligence in Pre-clinical Drug Development for AD/ADRD (R01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-24-049 |
| Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) |
93.273 |
PA-25-163 |
| Alcohol Health Services Research (R01 Clinical Trial Optional) |
93.273 |
PA-25-245 |
Search Results 361-400 of 15496
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 [Next] |
